Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients.

Stergios LazarinisNils P HailerJosef D JärhultAnders Brüggemann

Published in: Antibiotics (Basel, Switzerland) (2023)

The incidence of PJI caused by rifampicin-resistant bacteria did not increase over the past 20 years. The risk of treatment failure in PJI caused by rifampicin-resistant bacteria is more than four times that caused by rifampicin-sensitive bacteria, highlighting the importance of limiting the development of rifampicin resistance.

Keyphrases

mycobacterium tuberculosis
pulmonary tuberculosis
end stage renal disease
risk factors
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
total hip
patient reported